100 related articles for article (PubMed ID: 37715442)
1. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro.
Vasques Raposo J; Rodrigues Carvalho Barros L; Ribas Torres L; Barbosa da Silva Pinto R; De Oliveira Lopes A; Mello de Souza E; Hernan Bonamino M; Salete de Paula V
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):19-23. PubMed ID: 37715442
[TBL] [Abstract][Full Text] [Related]
2. [A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture].
Karpov DS; Karpov VL; Klimova RR; Demidova NA; Kushch AA
Mol Biol (Mosk); 2019; 53(1):91-100. PubMed ID: 30895956
[TBL] [Abstract][Full Text] [Related]
3. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
[TBL] [Abstract][Full Text] [Related]
4. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
[TBL] [Abstract][Full Text] [Related]
5. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
[TBL] [Abstract][Full Text] [Related]
6. Developing oncolytic
Ebrahimi S; Makvandi M; Abbasi S; Azadmanesh K; Teimoori A
Iran J Basic Med Sci; 2020 Jul; 23(7):937-944. PubMed ID: 32774817
[TBL] [Abstract][Full Text] [Related]
7. RNA interference inhibits herpes simplex virus type 1 isolated from saliva samples and mucocutaneous lesions.
Silva AP; Lopes JF; Paula VS
Braz J Infect Dis; 2014; 18(4):441-4. PubMed ID: 24835621
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 Mutagenesis of UL21 in Multiple Strains of Herpes Simplex Virus Reveals Differential Requirements for pUL21 in Viral Replication.
Finnen RL; Banfield BW
Viruses; 2018 May; 10(5):. PubMed ID: 29762484
[TBL] [Abstract][Full Text] [Related]
9. Herpes Simplex Virus 1 Mutant with Point Mutations in
Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HSV-1 Replication by Gene Editing Strategy.
Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
[TBL] [Abstract][Full Text] [Related]
11. Integrated CRISPR-Cas9 System-Mediated Knockout of IFN-γ and IFN-γ Receptor 1 in the Vero Cell Line Promotes Viral Susceptibility.
Kim S; Nowakowska A; Kim YB; Shin HY
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897807
[TBL] [Abstract][Full Text] [Related]
12. Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice.
Yin D; Ling S; Wang D; Dai Y; Jiang H; Zhou X; Paludan SR; Hong J; Cai Y
Nat Biotechnol; 2021 May; 39(5):567-577. PubMed ID: 33432198
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of herpes simplex virus type 1 by small interfering RNA.
Zhang YQ; Lai W; Li H; Li G
Clin Exp Dermatol; 2008 Jan; 33(1):56-61. PubMed ID: 17979991
[TBL] [Abstract][Full Text] [Related]
14. Role of the Orphan Transporter SLC35E1 in the Nuclear Egress of Herpes Simplex Virus 1.
Maeda F; Kato A; Takeshima K; Shibazaki M; Sato R; Shibata T; Miyake K; Kozuka-Hata H; Oyama M; Shimizu E; Imoto S; Miyano S; Adachi S; Natsume T; Takeuchi K; Maruzuru Y; Koyanagi N; Jun A; Yasushi K
J Virol; 2022 May; 96(10):e0030622. PubMed ID: 35475666
[TBL] [Abstract][Full Text] [Related]
15. Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.
Cantatore A; Randall SD; Traum D; Adams SD
BMC Complement Altern Med; 2013 Jun; 13():139. PubMed ID: 23777309
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sodium polyanethol sulfonate on herpes simplex virus-1 infection in vitro.
Li J; Cheng C; Lin T; Xue R; Liu X; Wu K
Mol Vis; 2022; 28():516-525. PubMed ID: 37089702
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
18. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.
Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y
PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394
[TBL] [Abstract][Full Text] [Related]
19. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
Zhong L; Hayward GS
J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.
Wang H; Davido DJ; Mostafa HH; Morrison LA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
